|
|
| | N,N-Dimethyl-4-pyrazolo[1,5-b]pyridazin-3-yl-2-pyrimidinamine Basic information |
| | N,N-Dimethyl-4-pyrazolo[1,5-b]pyridazin-3-yl-2-pyrimidinamine Chemical Properties |
| density | 1.34±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted) | | solubility | DMSO: Slightly soluble: 1-10 mg/ml Ethanol: Slightly soluble: 0.1-1 mg/ml | | pka | 3.04±0.10(Predicted) | | form | Solid | | color | White to off-white |
| | N,N-Dimethyl-4-pyrazolo[1,5-b]pyridazin-3-yl-2-pyrimidinamine Usage And Synthesis |
| Uses | DYRK1-IN-1 is a highly selective and ligand-efficient DYRK1A inhibitor. DYRK1-IN-1 inhibits DYRK1A phosphorylation activity with an IC50 value of 220 nM. DYRK1-IN-1 can be used for the research of central nervous system penetrant DYRK1A chemical probe[1]. | | in vivo | DYRK1-IN-1 (1 mg/kg; i.v.) shows high clearance[1]. | Animal Model: | SpragueDawley rats[1] | | Dosage: | 1 mg/kg (Pharmacokinetic Analysis) | | Administration: | I.v. | | Result: | High clearance was observed.
|
| | IC 50 | DYRK1A: 220 nM (IC50); DYRK1A: 3 nM (Kd); DYRK1B: 56 nM (Kd) | | References | [1] Henderson SH, et al. Discovery and Characterization of Selective and Ligand-Efficient DYRK Inhibitors. J Med Chem. 2021;64(15):11709-11728. DOI:10.1021/acs.jmedchem.1c01115 |
| | N,N-Dimethyl-4-pyrazolo[1,5-b]pyridazin-3-yl-2-pyrimidinamine Preparation Products And Raw materials |
|